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ABSTRACT The capacity to resist the bactericidal action of complement (C=) is a
strong but poorly understood virulence trait in Klebsiella spp. Killing requires activa-
tion of one or more C= pathways, assembly of C5b-9 membrane attack complexes
(MACs) on the surface of the outer membrane (OM), and penetration of MACs into
the target bilayer. We interrogated whole-genome sequences of 164 Klebsiella iso-
lates from three tertiary hospitals in Thailand for genes encoding surface-located
macromolecules considered to play a role in determination of C= resistance. Most
isolates (154/164) were identiﬁed as Klebsiella pneumoniae, and the collection con-
formed to previously established population structures and antibiotic resistance pat-
terns. The distribution of sequence types (STs) and capsular (K) types were also typi-
cal of global populations. The majority (64%) of isolates were resistant to C=, and the
remainder were either rapidly or slowly killed. All isolates carried genes encoding
capsular polysaccharides (K antigens), which have been strongly linked to C= resis-
tance. In contrast to previous reports, there were no differences in the amount of
capsule produced by C=-resistant isolates compared to C=-susceptible isolates, nor
was there any correlation between serum reactivity and the presence of hypermuco-
viscous capsules. Similarly, there were no correlations between the presence of
genes specifying lipopolysaccharide O-side chains or major OM proteins. Some viru-
lence factors were found more frequently in C=-resistant isolates but were consid-
ered to reﬂect clonal ST expansion. Thus, no single gene accounts for the C= resis-
tance of the isolates sequenced in this study.
IMPORTANCE Multidrug-resistant Klebsiella pneumoniae is responsible for an increas-
ing proportion of nosocomial infections, and emerging hypervirulent K. pneumoniae
clones now cause severe community-acquired infections in otherwise healthy indi-
viduals. These bacteria are adept at circumventing immune defenses, and most sur-
vive and grow in serum; their capacity to avoid C=-mediated destruction is corre-
lated with their invasive potential. Killing of Gram-negative bacteria occurs following
activation of the C= cascades and stable deposition of C5b-9 MACs onto the OM. For
Klebsiella, studies with mutants and conjugants have invoked capsules, lipopolysac-
charide O-side chains, and OM proteins as determinants of C= resistance, although
the precise roles of the macromolecules are unclear. In this study, we sequenced
164 Klebsiella isolates with different C= susceptibilities to identify genes involved in
resistance. We conclude that no single OM constituent can account for resistance,
which is likely to depend on biophysical properties of the target bilayer.
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Klebsiella pneumoniae is a prime cause of systemic nosocomial and community-acquired infections in immunocompromised individuals and, increasingly, healthy
individuals (1–3). K. pneumoniae has for many years been implicated as a causative
agent of pneumonia, bacteremia, wound infections, urinary tract infections, and men-
ingitis in hospitalized patients. The therapeutic challenges posed by K. pneumoniae
have been compounded by the capacity of these ubiquitous opportunistic pathogens
to acquire resistance to a wide range of antibiotics, notably carbapenems and other
broad-spectrum -lactam agents (4). Resistance is also emerging against tigecycline (5)
and colistin (6), drugs of last resort for the treatment of multidrug-resistant infections.
In recent years, hypervirulent K. pneumoniae clones associated with pyogenic liver
abscesses, pneumonia, and meningitis in younger, otherwise healthy patients have
emerged; such isolates have acquired genetic traits associated with increased virulence,
and while the majority are currently susceptible to antibiotics, drug-resistant hyper-
virulent isolates are beginning to emerge (1, 3). The trend toward untreatable, invasive
infections shows no signs of abating (7, 8), and new therapies are badly needed to
extend treatment options for these life-threatening infections.
The targeting of bacterial determinants required for virulence is a chemotherapeutic
approach that is gathering interest, and there is some evidence that inhibiting the
expression of key virulence factors can resolve bacterial infections in animal models
(9–11). K. pneumoniae characteristically produces copious amounts of capsular poly-
saccharide, and these K antigens are well-established virulence factors contributing to
invasive disease (1, 12). However, relatively few other K. pneumoniae virulence deter-
minants have been implicated in systemic infection, although lipopolysaccharide (LPS)
O-side chains, iron acquisition systems such as siderophores, and adhesins, which vary
in frequency among clinical isolates, contribute to disease severity in animal models of
infection and are common in hypervirulent isolates (1, 8, 13, 14). The complement (C=)
system is a ﬁrst line of defense against systemic invasion by microbial intruders that
have penetrated the host’s epithelial barriers, and evasion of the C= system greatly
enhances the capacity of Gram-negative pathogens to survive and multiply in blood
and in the major organs (15). Hypervirulent K. pneumoniae clinical isolates belong
predominantly to capsule serotype K1 and to a lesser extent K2 (ST23 and ST86; 16) and
tend to be refractory to the bactericidal action of complement (17). Loss by mutation
of wzy_K1 (previously magA), the serotype K1 capsule polymerase gene (18), trans-
formed hypervirulent strains to extreme C= susceptibility, strongly implicating the
capsule as a determinant of C= resistance (17).
A comprehensive understanding of the mechanisms of K. pneumoniae C= resistance,
which is currently lacking, is likely to enable identiﬁcation of additional targets for
therapeutic intervention or new strategies for augmentation of host defenses. A limited
number of enterobacteria avoid C=-mediated attack by preventing activation of all
three C= pathways. Bacterial activation of the classical, lectin, or alternative pathways
results in covalent binding of C3 cleavage products to the bacterial surface, formation
of a C5 convertase and generation of the C5b-9 membrane attack complex (MAC) (19,
20). Following cleavage of C5, each molecule of the larger fragment C5b initiates
assembly of a MAC by recruiting single molecules of C6, C7, and C8; multiple copies (up
to 18) of C9 join the membrane-embedded C5b-8 assembly to form the membrane-
perturbing MAC. Intercalation of C5b-9 containing at least two copies of pore-forming
C9 into lipid domains of the outer membrane (OM) results in killing of susceptible bacterial
targets (21, 22). Thus, enterobacterial C= resistance is usually due to the inability of
C5b-9 complexes to assemble at the bacterial surface or insert in stable fashion into the
OM, with the consequence that no C5b-9 can be found in stable association with this
bilayer (19–21). Capsules and long and numerous LPS O-side chains undoubtedly play
a role in determining resistance by preventing C= activation or access of C= components
to the surfaces of Gram-negative bacteria, including K. pneumoniae (23), although
nonencapsulated forms may be resistant to C= and encapsulated forms may be
susceptible to C= (19).
While not yet proven, it may be that the architecture of the external surface of the
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OM strongly inﬂuences the capacity of pore-generating C9 to perturb the integrity of
the OM. Thus, the surfaces of C=-susceptible strains may contain sufﬁcient numbers of
exposed lipid domains to facilitate C5b-9 generation and penetration, whereas the
spatial and temporal organization of the OM of resistant bacteria may be dominated by
recently identiﬁed supramolecular protein assemblages (24) to a degree where there
are insufﬁcient hydrophobic domains to act as C5b-9 assembly and binding sites. OM
proteins, such as plasmid-encoded TraT (25) or bacteriophage-derived Iss (26) and Bor
(27), have been implicated as determinants of C= resistance, but these studies employed
gene transfer into C=-susceptible genetic backgrounds, leading to insertion into the OM
bilayer of protein copy numbers (20,000 molecules per cell) far in excess of those
found naturally. Insertion of large numbers of protein molecules into the OM will
almost certainly alter the biophysical properties of the bilayer, reducing the surface area
and ﬂuidity of lipid patches that are essential for binding and assembly of the MAC.
Similarly, identiﬁcation of OM proteins contributing to C= resistance by gene deletion
risks disrupting the integrity of the OM, enabling C5b-9 insertion and membrane
perturbation, and may be unrelated to any functions ascribed to such proteins;
complementation simply restores the functional integrity of the OM. In the study
reported here, we have adopted a different approach: we determined whole-genome
sequences of 164 recent C=-susceptible and C=-resistant Klebsiella isolates from three
tertiary care hospitals in Thailand and probed the sequence data for correlates to C=
reactivity. We determined that the amount of capsule produced, hypermucoviscosity,
and the presence of genes encoding LPS O-side chains, the major OM proteins, and
virulence determinants were unable to explain the reactivity to human serum C= of the
isolates.
RESULTS
The genomes of 164 presumptive Klebsiella pneumoniae isolates derived from blood,
urine, pus, sputum, and ascitic ﬂuid samples by routine culture from three hospitals in
Thailand were sequenced; 30 isolates were from Thammasat University Hospital,
Pathum Thani Province, 89 isolates were from Siriraj Hospital, Bangkok, and 45 isolates
were from Songklanagarind Hospital, Hat Yai, Songkhla Province (see Data Set S1 in the
supplemental material). Siriraj is the largest hospital in Thailand with 2,300 beds,
1,000,000 outpatients per annum, and 80,000 inpatients per annum; equivalent ﬁgures
for Songklanagarind are 846, 1,019,375, and 40,936, respectively, and for Thammasat,
601, 384,088, and 40,745, respectively (all data from 2017).
The large majority of isolates (154 of 164) were identiﬁed as K. pneumoniae sensu
stricto, the species most closely associated with human infection (7). The remaining 10
isolates belonged to the species Klebsiella quasipneumoniae, which is part of the K.
pneumoniae species complex comprising K. pneumoniae sensu stricto, K. quasipneu-
moniae, and K. variicola. All show the same clinical manifestation and are routinely
diagnosed as K. pneumoniae. Phylogenetic analysis of our data in the context of a global
collection (7) demonstrates that the Thai collection is representative of the global
population structure (Fig. 1A). Core gene SNPs were used to determine the population
structure of the K. pneumoniae Thai isolates (Fig. 1B). The phylogenetic tree supports
the deep-branching, star-like population structure proposed by Holt et al. (7) for K.
pneumoniae that indicates early radiation into a large number of distinct, equally
distant lineages. The most common sequence types (STs) were ST147 (7.3%), ST23
(6.1%), ST16 (5.5%), and ST15 (5.5%); other STs each accounted for 5% (Fig. 1B).
European and Asian isolates of ST147 and ST15 are characterized by multidrug resis-
tance (2, 28, 29). Interestingly, ST16 is associated with sporadic infections in the United
Kingdom and southern Europe (2, 30). ST23 isolates often display the hypervirulent
phenotype that is strongly associated with community-acquired liver abscesses in the
Far East (31) and produce a hypermucoviscous K1 capsule linked to C= resistance (17).
Presence of antibiotic resistance genes. Acquired antimicrobial resistance (AMR)
genes were determined with the curated AMR database tool ARG-ANNOT using Ariba.
The core chromosomal SHV (-lactamase) and oxqAB (conferring low-level resistance to
Complement Susceptibility of K. pneumoniae
November/December 2018 Volume 3 Issue 6 e00537-18 msphere.asm.org 3
 o
n
 January 15, 2019 by guest
http://m
sphere.asm
.org/
D
ow
nloaded from
 
Tree scale: 0.1
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A
B
Songklaragarind
Songklaragarind
FIG 1 Population structure of Klebsiella clinical isolates. (A) Phylogenetic tree based on the core gene SNP alignment of
164 Thai Klebsiella genomes, 247 genomes from the global K. pneumoniae collection (7). (B) Phylogeny of core gene SNPs
from 154 K. pneumoniae Thai isolates. Isolates from Tammasat University Hospital, Siriraj Hospital, and Songklanagarind
Hospital are designated TU, SR, and SG, respectively; details can be found in Data Set S1 in the supplemental material.
Sequence types (STs) are shown as indicated in the legend.
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quinolones) genes were found in 100 and 98% (164 and 161 isolates, respectively) of
the Thai isolates. The proportion of K. pneumoniae isolates carrying acquired AMR genes
(Fig. S1) was generally comparable to the global pattern established by Holt et al. (7).
The rifampin resistance gene arr was present in 18% (27/154) of isolates, a similar
incidence to that reported in Vietnamese isolates (7); arr was, however, enriched in the
Songklanagarind isolates compared to those from Siriraj and Thammasat, with 40%
(15/38) carrying this gene. The quinolone resistance gene qnrB was also found more
frequently in Songklanagarind isolates than those from the other two hospitals (29%
compared to 14% overall; 12/38 compared to 22/154), and the frequency of isolation
was higher than that reported for the global collection (7). The majority (95% [36/38])
of Songklanagarind isolates carried blaCTX-M genes compared to 48% (72/154) overall in
the Thai collection; tetA (71% [27/38]; 39% [60/154] overall) was also enriched in
Songklanagarind isolates. Thammasat isolates carried fewer AMR genes compared to
isolates from Songklanagarind and Siriraj. NDM-1 carbapenemase was found in 8%
(7/88) of Siriraj isolates and in ST14-16 lineages. PlasmidFinder revealed the presence of
39 previously identiﬁed plasmid replicons in 146 of the 164 Thai isolates.
C= susceptibility of K. pneumoniae isolates. The method employed to determine
susceptibility to pooled human serum (32) enabled the isolates to be assigned to one
of three categories: resistant (R), delayed susceptible (DS), and rapidly susceptible (S).
Examples of these serum responses are shown in Fig. 2. R isolates showed no reduction
in viable count during the 3-h incubation period, DS isolates displayed 10% survival
after 1-h incubation and90% after 3-h incubation, and the inoculum of S isolates was
reduced to 10% after 1-h incubation. C=-susceptible enterobacteria that express long
and numerous LPS O-side chains (smooth phenotype) typically exhibit a delayed
response of at least 1 h, whereas strains lacking the O-side chain moiety of LPS (rough
phenotype) are usually promptly killed by C=, although occasional clinical isolates with
rough phenotype exhibit delayed serum sensitivity due to the presence of a polysac-
charide capsule (33). Fully C=-resistant isolates are invariably of the smooth phenotype
(19, 34). Susceptibility of all 164 Klebsiella isolates to human serum is summarized in
Fig. 2. The majority (64%) were complement resistant; susceptible isolates were equally
split between DS and S phenotypes.
Relationships between capsules, presence of LPS O-side chain genes, and
reactivity of K. pneumoniae to human serum. Sequencing of K. pneumoniae clinical
S (%)  DS (%)
60 (67) 13 (15) 16 (18)
21 (70) 7 (23) 2 (7)
24 (53) 10 (22) 11 (24)
R (%)Hospital
Siriraj
Thammasat
Songklanagarind
Total 105 (64) 30 (18) 29 (18)
(h)
FIG 2 Susceptibility of 164 Thai K. pneumoniae/K. quasipneumoniae isolates to the C=-mediated bacte-
ricidal action of pooled normal human serum. Isolates were classiﬁed as C= resistant (R) (no reduction in
viable count during the 3-h incubation period), delayed susceptible (DS) (10% survival after 1-h
incubation, 90% after 3-h incubation), or rapidly susceptible (S) (10% after 1-h incubation) (the
percentage of the total from each hospital is shown at the bottom of the ﬁgure). Two examples of each
category are shown, and all determinations were performed at least twice on different days. The
TU29 and TU34 isolates are C= R, the SG97 and TU32 isolates are C= DS, and the SR28 and SR37
isolates are C= S.
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isolates has revealed that the pathogen produces few virulence factors that speciﬁcally
target the host’s tissues or immune system (3). Rather, K. pneumoniae has adopted a
strategy of navigation and negation of host immune defenses mediated by capsule,
LPS, ﬁmbriae, siderophores, urease, and efﬂux pumps to protect against phagocytosis,
antimicrobial peptides, and C=-mediated killing (1). Capsules have received a great deal
of attention as key surface determinants contributing to C= resistance, as poorly
encapsulated and nonencapsulated mutant bacteria appear to bind more C3 than K.
pneumoniae clinical isolates displaying more extensive capsules (35, 36); loss of capsular
polysaccharide sometimes (17) but not always (37, 38) leads to increased susceptibility
to C=. In addition, capsular hypermucoviscosity is correlated with C= resistance in
liver-invasive strains (17), and the presence of sialic acid as a capsular component of
hypervirulent K. pneumoniae (39) may reduce C= susceptibility by facilitating the
binding of factor H to C3b to prevent activation of the alternative pathway (40). We
determined the capsular (K) and LPS O-side chain (O) serotypes by in silico typing (41,
42) and investigated the presence of genes conferring the capacity to synthesize sialic
acid. Capsule hypermucoviscosity was determined using the string test (17) and
correlated with the presence or absence of rmpA. Capsule surface area was measured
by light microscopy in order to examine K. pneumoniae isolates for correlates with C=
susceptibility.
All K. pneumoniae isolates were encapsulated, as determined by the presence of
K-antigen biosynthesis gene clusters (Fig. 3) and by India ink negative staining (Fig. S2).
In accord with other studies (7, 41, 42), there was a high degree of diversity of K
serotypes. Fifty-nine distinct K types were represented with two isolates of unknown,
probably novel, K type; K2 (10.4%), K51 (7.1%), K1 (6.5%), K10 (6.5%), K20 (4.5%), and
K24 (4.5%) were frequently encountered, and some differences between sources within
Thailand were evident (Fig. 3 and Fig. S2). For example, K1 and K2 were common in
Siriraj isolates, and K102 represented a larger proportion of Songkhlanagarind isolates
compared to the other two sources. The wide range of K types was distributed among
a relatively small number (nine) of O types (Fig. 3 and Fig. S3). All K1 (all ST23) and K10
(eight ST147, one each of ST45 and ST629) isolates were C= resistant (both 10/10),
whereas C=-susceptible isolates were well represented among K2 (6/16), K51 (6/11), and
K24 (3/7) isolates. All three K74 isolates (two ST147 isolates and one ST273 isolate) were
sensitive to C= (Table S1).
The size of the capsule for each isolate was determined by negative imaging with
India ink. Calculation of the area occupied by the capsule was determined from
micrographs using CellProﬁler image analysis software (Fig. 4); 40 to 100 cells were
measured in each preparation, and differences between C=-resistant and -susceptible
groups were compared by ANOVA. There was some variation in capsule size within
each sample, but no signiﬁcant differences (P  0.79; resistant versus susceptible) in
mean capsule area between C=-resistant (mean, 3.36 0.94 m2), S (3.23 1.43 m2),
and DS (3.26 1.06 m2) isolates (Fig. 4). The presence of a hypermucoviscous capsule
was identiﬁed by formation of viscous strings 5 mm in length when stretched from a
colony on a sheep blood agar plate (17). We examined Thai K. pneumoniae isolates for
hypermucoviscous capsules following overnight growth on sheep blood agar. There
was no signiﬁcant relationship between C= reactivity and hypermucoviscosity: 48/105
isolates were C= resistant, 13/29 were DS, and 19/30 S isolates were string test positive
(2 test of independence, 2 3.1194, P 0.21). The hypermucoviscosity trait was associ-
ated with most of the major K types in the collection, and all but one K. pneumoniae K1
isolate were string test positive. There was a strong association (28/30) between a
positive string test and the presence of rmpA; this gene regulates the mucoid pheno-
type by activating capsule production (31, 43). The uronic acid component of capsular
polysaccharides from selected strains was estimated by using the sodium tetraborate
reaction as an alternative chemical method to estimate capsule content. Partially
puriﬁed capsular polysaccharides from logarithmic phase cultures of 10 isolates be-
longing to each susceptibility group were examined. Isolates were selected to cover the
range of capsule areas as determined by negative staining: as with the India ink
Loraine et al.
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method, there were no signiﬁcant differences in the amount of uronic acid associated
with the capsule extracts (Fig. S4).
Of genes and gene products associated with sialic acid synthesis and polymer
export in Escherichia coli (44), only NeuB has been found in K. pneumoniae (UniProt
FIG 3 Capsular (K) and LPS O antigen in silico typing of Thai K. pneumoniae isolates. The phylogenetic tree is as shown in Fig. 1B. The
K and O types as well as C= susceptibility and isolate source are shown as indicated in the ﬁgure.
Complement Susceptibility of K. pneumoniae
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accession no. A0A1C3SZN5). We derived the DNA sequence of this protein and
screened the Thai K. pneumoniae sequences with Ariba for evidence of neuB: none was
found. In contrast, nanT, encoding a sialic acid transport protein associated with
intracellular catabolism and inducible by the substrate (44), was present in 161 of 164
Klebsiella genomes.
Relationship between OM proteins and C= susceptibility. Two major Klebsiella
OM proteins, OmpK35 and OmpK36, are closely associated with antibiotic resistance
(45, 46). There is no publicly accessible Klebsiella OM protein database. We therefore
constructed customized Ariba gene databases for these two proteins and for LppA, Pal,
and OmpK17; these three proteins have been linked to C= resistance in K. pneumoniae,
Salmonella enterica serotype Typhimurium, and other enterobacteria (47, 48). ompK35
and ompK36 were detected in all 164 Thai isolates. In 21 isolates, ompK35 was either
fragmented or interrupted, but there was no association between these isolates and C=
resistance. ompK17 and pal were present in all 164 strains, and lppA was present in all
but four isolates. Therefore, no clear associations between genes encoding these
proteins and susceptibility to C= were evident. However, in order to fully investigate
potential associations, a comprehensive curated OM protein database and monitoring
of gene expression will be required.
Virulence determinants of K. pneumoniae isolates. Iron-sequestering systems
have been implicated in the determination of C= resistance through their role in
metabolic adaptation (49, 50) and are considered major virulence effectors in Klebsiella
infections (1, 7, 51). We examined the distribution of established virulence genes (7, 52)
among the 154 K. pneumoniae Thai isolates (Fig. 5). The iron-sequestering siderophores
aerobactin, salmochelin, and yersiniabactin were widely distributed among these iso-
lates. C=-resistant ST23 K1 serotype isolates were enriched for colibactin, microcin, and
other virulence genes compared to isolates from other STs and K serotypes. Such
isolates are strongly associated with highly invasive infections (7). As expected (1, 7, 52),
virtually all isolates carried genes for elaboration of ﬁmbriae. Genes encoding compo-
nents involved in metabolism of allantoin, enabling utilization of this metabolite under
aerobic conditions, were restricted to ST23 K1 isolates; hypervirulent K. pneumoniae use
this capacity to enhance virulence (1). Although colibactin genes were associated
exclusively with C=-resistant isolates, they were carried by only a small number of
isolates. Other virulence determinants were distributed throughout C=-resistant, DS,
and S groups. There were no clear associations between C= resistance and any one set
of virulence genes (Fig. S5).
FIG 4 Capsule size of Klebsiella isolates in relation to C= susceptibility. Distribution of capsule size between groups based on C= reactivity.
The area (m2) occupied by capsule for each isolate was determined by CellProﬁler image analysis of 40 to 100 individual bacteria. R, C=
resistant; DS, C= delayed susceptible; S, C= rapidly susceptible. P values were determined by ANOVA. The lower and upper hinges of the
boxplots correspond to the ﬁrst and third quartiles (25th and 75th percentiles). Isolates carrying rmpA (regulator of the mucoid phenotype
A gene) are indicated.
Loraine et al.
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DISCUSSION
Both humoral and cellular defenses are considered important for prevention of
tissue and blood invasion by Klebsiella spp. Although K. pneumoniae is considered to be
a predominantly C=-resistant pathogen (1), there have been surprisingly few studies
delineating the degree of C= resistance among clinical isolates. Recent evidence has
FIG 5 Virulence genes associated with Thai K. pneumoniae isolates. The guidance tree is as shown in Fig. 1B. Virulence genes were predicted using Ariba based
on the BIGsDB virulence genes described for K. pneumoniae (7).
Complement Susceptibility of K. pneumoniae
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emphasized that survival of K. pneumoniae in blood is, along with a capacity to counter
phagocytosis by macrophages and neutrophils, a critical virulence trait associated with
systemic invasion (53, 54). Indeed, neutrophils may aid the dissemination and estab-
lishment of secondary sites of infection by hypervirulent K. pneumoniae (55). Sahly and
coworkers (56) examined the serum susceptibility of an international collection of
nosocomial K. pneumoniae isolates in relation to extended-spectrum -lactamase (ESBL)
production. After they excluded clonal strains, they found that 36% (17/47) of ESBL
producers and 16% (27/166) of non-ESBL producers were C= resistant (56), suggesting
a greater pathogenic potential for ESBL-producing isolates. In another study, six ST258
clinical isolates displayed a wide range of responses to C= in whole human blood (53),
emphasizing a more complex association between invasive potential and C= suscepti-
bility than previously recognized. In the current study, the majority (64%) of isolates
were fully resistant to C=, but the relative abundance of susceptible isolates provided an
opportunity to examine the basis of differences in C= reactivity of K. pneumoniae
without resort to the generation of mutants lacking key surface components.
Prevention of C= activation or the failure of MACs to insert into the target OM bilayer
of Gram-negative bacteria is a reﬂection of the distribution of macromolecules at the
bacterial surface. A limited number of studies have shown that both C=-resistant and
C=-susceptible strains of K. pneumoniae are able to activate the classical and alternative
pathways to various degrees (53, 57, 58), but there has been no systematic evaluation
of relationships between the degree of activation, deposition onto the surfaces of key
proteins such as C3b and C5b-9, and bacterial killing or of the capacity of major surface
components such as capsule, LPS O-side chains, and proteins to modulate activation.
The recent recognition that K. pneumoniae capsules may incorporate sialyl residues (39,
59), with the potential to prevent activation of the alternative pathway (40), would
make such an analysis a key to understanding C= resistance mechanisms in this
bacterial species.
Capsules are considered likely determinants of C= resistance in K. pneumoniae (1, 23),
as they function as macromolecules that reduce binding to the surfaces of key
components of the cascade such as C3b (35, 60) and prevent MAC formation or
insertion into the OM bilayer (17, 61). Most importantly, selective removal of the
polysaccharide capsule using bacteriophage-associated depolymerases increases C=
susceptibility and enhances survival of K. pneumoniae-infected mice (62–64). However,
we found no evidence that differences in the quantity or viscosity of capsule produced
by isolates from our Thai collection could be responsible for their reactivity in serum.
As anticipated, we encountered a wide range of STs and K types, and although isolates
from the same clonal lineages, such as the ST23 K1 serotype isolates (SR5 through SR29;
Fig. 3), tended to respond to exposure to C= in a similar fashion, the limited numbers
of isolates in each ST or K serogroup were too low to draw ﬁrm conclusions with regard
to differences in serum susceptibility between lineages and capsule types. However, the
basis of C= resistance in Gram-negative bacteria is related to the biophysical nature of
the target for C= deposition, the OM, and to the capacity of structures beyond the OM
surface to prevent C= activation, not to the chemical nature of surface macromolecules
(15, 19, 21). The major K. pneumoniae chemotypes do not prevent C= activation (1, 23,
37), and the current study shows that the most common K, O, and ST groups contain
both C=-resistant and -susceptible isolates (Fig. 3; see also Table S1 in the supplemental
material). Determination of C= surface binding and deposition on isolates belonging to
such categories but displaying different serum reactivity would resolve this limitation of
the current study.
Overall, the amount of capsule produced was remarkably similar between C=-
resistant and -susceptible isolates (Fig. 4), regardless of whether chromosomal rmpA
was present. rmpA was present in only 30 of the Thai isolates, including all isolates of
the ST23 K1 clonal lineage, and these isolates did not produce more capsule as
determined by negative staining than the rmpA-negative isolates did. Some C=-
susceptible isolates carried rmpA. It is unclear why the rmpA-positive isolates did not
produce increased amounts of capsule; Cheng et al. (43) showed that deletion of rmpA
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in a K. pneumoniae K2 strain resulted in formation of small colonies with signiﬁcantly
reduced capsule viscosity. Viscosity could be restored by gene complementation but
only in tandem with rcsB, suggesting that cooperation between RmpA and the cyto-
plasmic response regulator RcsB is required for regulation of capsule expression.
It is contended that enhanced capsule production mediated by RmpA results in the
hypermucoviscosity phenotype (31, 43); we show a strong association (28/30) between
rmpA carriage and hypermucoviscosity as determined by the string test after growth on
blood agar. In solution, viscosity is inﬂuenced by polymer composition, molecular
weight, concentration, and internal friction between the randomly coiled and swollen
macromolecules and surrounding solvent molecules (65). The relationships between
these parameters are inevitably more complex and difﬁcult to control if the polymer is
present within a bacterial colony on an agar plate, as in the string test; rmpA-mediated
increases in the amount of polymer produced may not necessarily lead to increases in
viscosity if there is no concomitant increase in the surrounding solvent water. Heating
(95°C for 30 min) of heat-stable capsule from hypermucoviscous K. pneumoniae KP-M1
signiﬁcantly reduced the mucoviscosity of the polymer (39), suggesting that the high
viscosity of capsules from such strains could be due to polysaccharide-protein com-
plexes that are disrupted by heat rather than being related directly to polymer
concentration. This possibility would seem worthy of investigation. We obtained no
genomic evidence for sialic acid synthesis in any isolates: in view of the chemical
diversity of sialic acid polymer building blocks and the consequent likelihood of
orthologs and paralogs of the neu operon genes in species other than E. coli (66), we
have initiated a biochemical rather than genomic search for evidence of capsule
modiﬁcation with sialyl residues among these isolates, which will be reported at a
later date.
Genes involved in the synthesis and assembly of LPS O-side chains were found in all
isolates from our Thai collection, regardless of their response to exposure to C=. In other
enterobacteria, O-side chains have been shown to increase the length of time before
initiation of C=-mediated cell death (the delayed response), but alone the side chains do
not account for complete C= resistance (19, 34, 67). This may not be the case with the
K. pneumoniae isolates, although the presence of these genes does not provide
information on the degree of substitution of the LPS core with O-side chains, a factor
known to be important in determining serum reactivity (67). C=-resistant K. pneumoniae
mutants lacking O-side chains were susceptible to serum (37), and it can be surmised
that, as with other enterobacteria, K. pneumoniae LPS with a high degree of substitution
of core with O-side chains is necessary but not sufﬁcient to confer full C= resistance (19).
Overall, the percentage of strains in our collection carrying acquired AMR genes
ﬁtted well with previous ﬁndings (7). In Thailand, isolates obtained from Songklana-
garind carried a higher proportion of these genes compared to isolates from Siriraj and
Thammasat. In general, K. pneumoniae isolates tend toward either hypervirulence or
multidrug resistance, although there have been recent reports of multidrug-resistant
hypervirulent clones (68). Notably, the hypervirulent ST23 Siriraj blood isolate KP29
contained genes encoding multiple virulence determinants and four aminoglycoside-
encoding genes, as well as blaTEM, dfrA, mphA, sul1, sul2, tetA, and tetR (Fig. 5 and
Fig. S1).
Variations in carriage of genes encoding aerobactin, salmochelin, and yersiniabactin,
enabling iron assimilation, were evident between clonal lineages; all three systems
were found in ST23 K1 serotype isolates, which were almost exclusively C= resistant, but
this association is unlikely to be directly related to their serum reactivity. Efﬁcient iron
sequestration is essential for survival and growth in serum; deletion of fur, encoding the
master regulator of the serum-induced transcriptional response, completely abrogates
C= resistance (69), highlighting the importance of metabolic competence to C= survival.
We found little or no variation in genes for the major OM proteins and no clear
relationship between antibiotic susceptibility patterns and susceptibility to C=. It has
been reported that C= resistance in K. pneumoniae is correlated with production of
ESBLs (57). K. pneumoniae and other Gram-negative bacteria producing ESBLs and
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November/December 2018 Volume 3 Issue 6 e00537-18 msphere.asm.org 11
 o
n
 January 15, 2019 by guest
http://m
sphere.asm
.org/
D
ow
nloaded from
 
carrying efﬂux pumps have altered OM surface protein expression compared to their
antibiotic-susceptible counterparts (70, 71), and these changes are likely to alter,
perhaps in subtle ways, the biophysical properties of the bilayer; this is turn may affect
the capacity of the C= components to bind to or insert into the bilayer. Thus, antibiotic
resistance machineries may have the capacity to alter susceptibility to C= in ways
unrelated to their speciﬁc function.
The data we and others have generated can be best reconciled by consideration of
the biophysical properties and surface architecture of the OM as a whole rather than by
invocation of “C= resistance genes” as has been frequently attempted in the past. C=
resistance is intimately linked to the capacity of structures at the bacterial surface to
either modulate activation of the C= cascades or prevent the stable deposition of MACs.
At the present time, we lack sufﬁcient understanding of the relationships between K.
pneumoniae surface topography, activation of each C= pathway, and the factors gov-
erning C5b-9 intercalation into the highly asymmetric OM to be able to deﬁne the
mechanistic basis of C= resistance for Klebsiella and other Gram-negative bacteria.
MATERIALS AND METHODS
Bacterial isolates and genome sequencing, assembly, and annotation. A total of 185 K. pneu-
moniae isolates were cultured from blood, urine, pus, sputum, and ascitic ﬂuid samples at the clinical
microbiology laboratories of three tertiary care hospitals in Thailand; 44 isolates were obtained from
Thammasat University Hospital, 100 isolates from Siriraj Hospital, and 46 isolates from Songklanagarind
Hospital. Thammasat and Songkhlanagarind isolates were obtained in April 2016 and August 2016,
respectively, and the Siriraj isolates represent consecutive laboratory isolates cultured in April 2016.
Virulent K. pneumoniae clinical isolate B5055 (serotype K2:O1) and capsule knockout derivative B5055nm
(72) were kindly provided by Richard Strugnell, University of Melbourne.
Bacteria were identiﬁed by routine biochemical tests for identiﬁcation of Gram-negative bacteria.
Genomic DNA was extracted and sequenced using Illumina-B HiSeq X paired-end sequencing. Annotated
assemblies were produced as previously described (73); sequence reads were assembled de novo using
Velvet v1.2 (74) and either VelvetOptimiser v2.2.5 (75) or SPAdes version 3.10 (76) and annotated using
PROKKA v1.11 (77). The stand-alone scaffolder SSPACE (78) was employed to reﬁne contig assembly, and
sequence gaps were ﬁlled using GapFiller (79). Contigs were annotated using PROKKA (77). Genomes
with greater than 5% contamination levels as determined by Kraken (80), fully assembled genomes of 5
Mbp or less and 6 Mbp or more as well as those comprising 500 or more contigs were removed. Putative
genomes with less than 60% sequence homogeneity with the reference genome were assessed with
CheckM (81) for genome completeness and contamination; isolates with greater than 3% contamination
levels were rejected. SNPs were called against the K. pneumoniae reference genome to identify heterozy-
gous SNPs (Het SNPs) and isolates with greater than 2% Het SNPs were removed from further analysis
(73), resulting in the 164 genomes analyzed in this study.
Bioinformatic analyses. The pan genome was determined with Roary (82), using a Protein BLAST
identity of 95% and a core deﬁnition of 99%. SNPs were extracted from the core gene alignment using
SNP sites (83) and the output used to run RAxML V8.2.8 (84) in order to calculate the phylogenetic tree
with 100 bootstraps under the GTR time-reversible model. Antibiotic resistance genes were detected
with the curated version of the ARG-ANNOT database available at the SRST2 site (85) using Ariba software
(86). Genomes were assigned to STs by mapping to known alleles with SRST2 in accordance with the K.
pneumoniae multilocus sequence typing (MLST) database (53). Virulence gene sequences were retrieved
from the K. pneumoniae BIGSdb database at Institut Pasteur (http://bigsdb.web.pasteur.fr) and predicted
using a custom-made Ariba database as described in the software manual (84). Plasmids were detected
with the PLasmidFinder database (87) using Ariba software. Representations of trees and metadata were
performed using iTOL (88) and the ggplot2 package in R (https://cran.r-project.org/web/packages/
ggplot2/ggplot2.pdf). Kaptive (42) was used to determine capsule (K-type) and O-antigen (O-type)
genotypes. Genes encoding OM proteins, components involved in sialic acid metabolism, and transport
genes were investigated using customized Ariba databases.
C= susceptibility. Susceptibility of K. pneumoniae isolates to commercial (MP Biomedicals UK) pooled
human sera was determined essentially as described previously (32). The quality-controlled sera (https://
www.mpbio.com/includes/msds/0929301/MP_COAT_0929301.pdf) were dispensed into small aliquots to
avoid freeze-thaw cycles and stored at80°C, and individual aliquots were thawed as required and used
immediately following previously described recommendation (32). DS and S control K. pneumoniae
isolates were employed during each assay run to ensure that storage conditions did not result in reduced
levels of bactericidal potency. Brieﬂy, early mid-logarithmic-phase Luria-Bertani (LB) broth cultures
(200 l) were washed three times in gelatin-veronal-buffered saline containing Mg2 and Ca2 (pH 7.35)
(GVB), suspended in 400 l of GVB, and mixed with 800 l of prewarmed (37°C) serum to give a
ﬁnal concentration of7.5	 106 CFU/ml. The mixtures were incubated at 37°C for 3 h, and bacteria were
quantiﬁed by serial dilution and incubation on LB agar overnight. Prewarmed, heat-inactivated (56°C for
30 min) serum served as a control.
Characterization of exopolysaccharide capsules. The string test (17) was used to identify isolates
producing hypermucoviscous capsular material. Strains were cultured on 5% sheep blood agar at 37°C
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overnight, and a standard bacteriological loop was employed to stretch a mucoid string from a colony:
hypermucoviscosity was deﬁned by the formation of viscous strings extending 5 mm in length. The
surface area occupied by capsule was determined by mixing bacterial suspensions in PBS with an equal
volume of India ink, applying to a microscope slide, attaching a coverslip, and obtaining photomicro-
graphic images with a Zeiss Axiostar plus transmitted light microscope ﬁtted with an Olympus SC30
digital camera and using a 100	 oil immersion lens and embedded scale bar. Images were analyzed with
CellProﬁler image analysis software (89). Capsule content of selected isolates was also determined by
precipitation of the polysaccharide followed by determination of uronic acid by modiﬁed carbazole
(sodium tetraborate) assay (90, 91).
Data availability. Data have been deposited in the European Nucleotide Archive under accession no.
ERP021210.
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